Sort by
Medicine and Dentistry
Otitis Media
100%
Randomized Controlled Trial
54%
Pneumococcus Vaccine
48%
Streptococcus pneumonia
44%
Serotype
43%
Pneumococcal Pneumonia
34%
Acute Otitis Media
32%
Haemophilus influenzae
32%
Pathogen
30%
Hearing Impairment
25%
Prevalence
23%
Respiratory Tract Infection
23%
Diseases
23%
Nontypeable Haemophilus Influenzae
20%
Chronic Suppurative Otitis Media
17%
Antibiotics
16%
Nasopharynx
16%
Aboriginal and Torres Strait Islander
15%
Infection
14%
Middle Ear
14%
Conjugate Vaccine
14%
Nasopharyngeal Swab
14%
Secretory Otitis Media
12%
Bronchiectasis
11%
High Risk Population
11%
Placebo
10%
Ear Disease
10%
Health Service
10%
Antibiotic Resistance
10%
Azithromycin
9%
Systematic Review
9%
Odds Ratio
9%
Moraxella catarrhalis
9%
Eardrum Perforation
9%
Pneumococcus Polysaccharide
8%
Pneumococcus
8%
Polysaccharide Vaccine
8%
Primary Health Care
8%
Tympanic Membrane
8%
Pneumococcal Infection
7%
Immunogenicity
7%
Attributable Risk
7%
Cohort Analysis
7%
Vaccine Efficacy
7%
Silo-Filler's Disease
7%
Clinical Trial
6%
Primary Outcome
6%
Health Promotion
6%
Malaria Vaccine
6%
Pediatrics
6%
Immunology and Microbiology
Otitis Media
72%
Haemophilus influenzae
51%
Streptococcus pneumonia
43%
Nontypeable Haemophilus Influenzae
40%
Serotype
39%
RTS,S
34%
Infectious Agent
31%
Infection
30%
Pneumococcal Vaccine
28%
Immunogenicity
24%
Prevalence
20%
Nasopharynx
16%
Pneumococcus
14%
Conjugate Vaccine
13%
Airway
13%
Middle Ear
12%
Moraxella catarrhalis
10%
Microbiology
10%
Bacterial Load
10%
Rabies Vaccine
9%
High Risk Population
9%
Antibiotic Resistance
8%
Real-Time Polymerase Chain Reaction
8%
Staphylococcus aureus
7%
Vaccine Efficacy
7%
Pneumococcal Polysaccharide Vaccine
7%
Haemophilus
6%
Antibody Blood Level
6%
Immune Response
6%
Haemophilus Influenzae Type B
5%
Vaccination Schedule
5%
Antibiotic Sensitivity
5%
Upper Respiratory Tract
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malaria Vaccine
41%
Randomized Controlled Trial
31%
Immunogenicity
24%
Pneumococcus Vaccine
23%
Otitis Media
22%
Vaccine Efficacy
19%
Haemophilus influenzae
16%
Prevalence
13%
Conjugate Vaccine
12%
Antibiotics
12%
Rabies Vaccine
12%
Nontypeable Haemophilus Influenzae
11%
Acute Otitis Media
10%
Diseases
10%
Adverse Event
10%
Infectious Agent
9%
Streptococcus pneumonia
8%
Hearing Impairment
8%
Malaria Falciparum
8%
Infection
7%
Clinical Trial
6%
Chronic Suppurative Otitis Media
6%
Hepatitis B Vaccine
6%
Azithromycin
5%
Circumsporozoite Protein
5%
Amoxicillin
5%
Respiratory Tract Infection
5%